FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

LALPATHLAB

2,232
-63.45 (-2.76%)
Updated 03:28 18/01 IST

LALPATHLAB Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for LALPATHLAB
Disclaimer
0% Bullish
0% Bearish

LALPATHLAB Buy or Sell - Brokerage Reports

No. of reports in last year
3
No. of analysts
1
Average Consensus Forecast
1232.67
Consensus Potential
-104.13%
See LALPATHLAB Share Price Targets >>

LALPATHLAB Ratings

Long term LALPATHLAB rating by FrontPage users
3.5/5 (2 Ratings)
Find answers to all your questions on live LALPATHLAB message board: Is LALPATHLAB buy or sell? Should I buy LALPATHLAB shares? Why are LALPATHLAB shares falling? Should I invest in LALPATHLAB stock?

  1. Home
  2. LALPATHLAB Forum

LALPATHLAB Share Price Discussion

N
Reputation: 10,122 • Today 4:58 AM
Dr. Lal PathLabs Q3 PAT Seen Up 27.4% YoY To Rs. 54.1 Cr: Prabhudas Lilladher
Net Sales are expected to increase by 16.1 percent Y-o-Y (down 11.8 percent Q-o-Q) to Rs. 327.9 crore, according to Prabhudas Lilladher.
Moneycontrol
Like
Reply
B
Reputation: 671 • Jan 15 3:17 AM

Type
Sell
Instrument
LALPATHLAB
Entry Price
₹2,311
Price@Trade
₹2,318.55
Target Price
₹2,266
Stop Price
₹2,355
Valid Till
Jan 15, 2021 3:20 AM
Margin
₹231,100 approx for 100 Qty
Status
Exited
Exit Price
₹2,295.3
Net P&L
+₹1,570 (+0.68%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Jan 15 5:00 AM

Update
Trade Entered
Entry Price
₹2,311
Bhaveek @bhaveek
Jan 15 8:48 AM

Update
Exited
Exit Price
₹2,295.3
Net P&L
+₹1,570 (+0.68%)

📍📍Thyrocare Technologies … significant business revival in Q3 . Positive for diagnostic stocks.. Expects positive for Lal Path, Metropolis

· Thyrocare says - significant business revival in Q3 after business activities resumed across all states. The non-Covid business in par...
Read more...
1
Reply

Type
Buy
Instrument
LALPATHLAB JAN21 2400 CE
Entry Price
₹95.8
Price@Trade
₹95.8
Target Price
₹120
Stop Price
₹89
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹23,950 approx for 250 Qty
Status
Exited
Exit Price
₹91.65
Net P&L
-₹1,037.5 (-4.33%)
Like
Reply (1)
See all replies

Update
Exited
Exit Price
₹91.65
Net P&L
-₹1,037.5 (-4.33%)

Lal path Labs CMP 2409
Lal path labs operates its own path labs, while collection centres are primarily run on a franchisee model. Though operations are spread across the country, northern India accounts for over 70% of total revenue.
Financial
- RO...
Read more...
2
Reply

Type
Buy
Instrument
LALPATHLAB JAN21 2500 CE
Entry Price
₹63.9
Price@Trade
₹63.9
Target Price
₹86
Stop Price
₹50
Valid Till
Jan 15, 2021 3:20 AM
Margin
₹15,975 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹50
Net P&L
-₹3,475 (-21.75%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 8 8:17 AM

Update
Stoploss Hit
Exit Price
₹50

Lal path Labs CMP 2409
Lal path labs operates its own path labs, while collection centres are primarily run on a franchisee model. Though operations are spread across the country, northern India accounts for over 70% of total revenue.
Financial
- RO...
Read more...
4
Reply
F
Reputation: 13,256 • Jan 7 4:42 AM

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,386
Price@Trade
₹2,386.1
Target Price
₹2,680
Stop Price
₹2,341  ₹2,420
Valid Till
Jan 14, 2021 3:20 AM
Margin
₹314,952 approx for 132 Qty
Status
Stoploss Hit
Exit Price
2420.0
Net P&L
+₹4,488 (+1.42%)
Like
Reply (4)
See all replies
FUTURE STOCKS EXPERT @magan
Jan 7 4:55 AM

Update
Stoploss Trailed
Price @ Update
₹2,393
Original SL
₹2,341
New SL
2383.0
FUTURE STOCKS EXPERT @magan
Jan 7 5:12 AM

Update
Stoploss Trailed
Price @ Update
₹2,421.4
Original SL
₹2,383
New SL
2420.0
TrackerBot @trackerbot
Jan 7 5:13 AM

Update
Stoploss Hit
Exit Price
2420.0

LALPATHLAB - 1892995

The stock gave trendline breakout in 15mins TF and broke 50EMA SUPPORT in 2HRS TF. Wait for the confirmation.
Like
Reply
F
Reputation: 13,256 • Jan 5 5:12 AM

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,400
Price@Trade
₹2,400
Target Price
₹2,458
Stop Price
₹2,375
Valid Till
Jan 6, 2021 3:20 AM
Margin
₹2,400 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹2,375
Net P&L
-₹25 (-1.04%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 5 7:42 AM

Update
Stoploss Hit
Exit Price
₹2,375

Type
Sell
Instrument
LALPATHLAB JAN21 2600 CE
Entry Price
₹46.1
Price@Trade
₹46.1
Target Price
₹35
Stop Price
₹50
Valid Till
Jan 1, 2021 3:20 AM
Margin
₹112,158.13 approx for 250 Qty
Status
Validity Over
Exit Price
₹46
Net P&L
+₹25 (+0.02%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 1 8:50 AM

Update
Validity Over
Exit Price
₹46
Net P&L
+₹25 (+0.02%)

Type
Buy
Instrument
LALPATHLAB JAN21 2500 CE
Entry Price
₹84
Price@Trade
₹84
Target Price
₹150
Stop Price
₹70
Valid Till
Jan 28, 2021 3:20 AM
Margin
₹21,000 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹70
Net P&L
-₹3,500 (-16.67%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Jan 1 7:05 AM

Update
Stoploss Hit
Exit Price
₹70
V
Reputation: 16,558 • Jan 1 3:21 AM
Like
Reply
1
Reply
Like
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,235.1
Price@Trade
₹2,235.1
Target Price
₹2,315
Stop Price
₹2,210
Valid Till
Dec 21, 2020 3:20 AM
Margin
₹223,510 approx for 100 Qty
Status
Exited
Exit Price
₹2,228.1
Net P&L
-₹700 (-0.31%)
Like
Reply (1)
See all replies
Piyush @piyush-Hkhv3rjnw
Dec 21, 2020 5:43 AM

Update
Exited
Exit Price
₹2,228.1
Net P&L
-₹700 (-0.31%)
RJ ROCKET TRADES in LALPATHLAB
**BUY LAL PATH LAB AT CMP** **CMP 2213** **TG 2...

*AND PROFIT MORNING START GUYS WITH RJ TEAM**
**LALPATHLAB NON STOP GUYS**
**2260 FROM 2213**
**T1 HIT**
**T2 HIT**
**T3 HIT**
**ENJOY THE GAINS WITH RJ TEAM✈️✈️✈️✈️**
**BE READY FOR ANOTHER JACKPOT COMING UP NEXT**
Like
Reply

**BUY LAL PATH LAB AT CMP**
**CMP 2213**
**TG 2230/2245/2260/2280**
**SL 2200**
Like
Reply

LALPATHLAB - 1706380
#LALPATHLAB WEEKLY CHART VIEW!!

Dr. Lal Pathlabs Ltd. is consolidating in an ascending triangle pattern and likely to see a breakout above swing high of 2395 level.

Technical parameters look positive as of now.

Immediate support comes at 2175 level.

Keep a close watch.
1
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,246.95
Price@Trade
₹2,246.95
Target Price
₹2,255
Stop Price
₹2,240
Valid Till
Nov 26, 2020 3:20 AM
Margin
₹2,246.95 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹2,240
Net P&L
-₹6.95 (-0.31%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Nov 26, 2020 3:14 AM

Update
Stoploss Hit
Exit Price
₹2,240
N
Reputation: 10,122 • Nov 23, 2020 4:01 AM
Add Dr. Lal Pathlabs, target price Rs 2430: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18504.65 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply
N
Reputation: 10,122 • Nov 17, 2020 5:26 AM
Buy Dr. Lal Pathlabs, target price Rs 2430: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18028.75 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,167
Price@Trade
₹2,167
Target Price
₹5,000
Stop Price
₹1,500
Valid Till
Nov 11, 2021 3:20 AM
Margin
₹173,360 approx for 80 Qty
Status
Exited
Exit Price
₹2,255.7
Net P&L
+₹7,096 (+4.09%)
Like
Reply (1)
See all replies
Kapil Sahu @kapilsahu
Nov 23, 2020 3:29 AM

Update
Exited
Exit Price
₹2,255.7
Net P&L
+₹7,096 (+4.09%)
N
Reputation: 10,122 • Nov 6, 2020 10:36 AM
Dr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 cr
Revenue from operations stood at Rs 431.9 crore for the quarter under consideration. It was Rs 365.6 crore for the same period a year ago, it added.​​
The Economic Times
Like
Reply
N
Reputation: 10,122 • Nov 6, 2020 9:03 AM
Dr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoY
Consolidated revenue for the said quarter came at Rs 431.9 crore, up 18 percent YoY from Rs 365.6 crore in the corresponding quarter of the previous financial year.
Moneycontrol
Like
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,350  ₹2,365
Price@Trade
₹2,358.6
Target Price
₹2,600
Stop Price
₹2,100
Valid Till
Nov 6, 2020 3:20 AM
Margin
₹709,500 approx for 300 Qty
Status
Exited
Exit Price
₹2,307.85
Net P&L
-₹17,145 (-2.42%)
Like
Reply (3)
See all replies

Update
Entry Price Modified
Price @ Update
₹2,370.8
Original Entry Price
₹2,350
New Entry Price
2365.0
TrackerBot @trackerbot
Nov 6, 2020 3:11 AM

Update
Trade Entered
Entry Price
2365.0

Update
Exited
Exit Price
₹2,307.85
Net P&L
-₹17,145 (-2.42%)

Type
Sell
Instrument
LALPATHLAB
Entry Price
₹2,301.95
Price@Trade
₹2,301.95
Target Price
₹2,237
Stop Price
₹2,325.35
Valid Till
Nov 3, 2020 3:20 AM
Margin
₹98,983.85 approx for 43 Qty
Status
Validity Over
Exit Price
₹2,286.1
Net P&L
+₹681.55 (+0.69%)
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Nov 3, 2020 8:50 AM

Update
Validity Over
Exit Price
₹2,286.1
Net P&L
+₹681.55 (+0.69%)
S
Reputation: -28,077 • Oct 30, 2020 9:53 AM
Like
Reply

LALPATHLAB - chart - 1527387
#LALPATHLAB MEDIUM TERM ABC BULLISH BO DONE TGT 2725/3359 SL 2050 ( WEEKLY CLBS )
Like
Reply
Post in Positional Trades (Swing,Momentum,Trending,Invest) channel on FrontPage
No access
FrontPage
Like
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,132
Price@Trade
₹2,132
Target Price
₹2,140
Stop Price
₹2,125  ₹2,131.4
Valid Till
Oct 12, 2020 3:20 AM
Margin
₹213,200 approx for 100 Qty
Status
Stoploss Hit
Exit Price
2131.4
Net P&L
-₹60 (-0.03%)
Like
Reply (4)
See all replies
Athul @athul-S1OeuliUP
Oct 12, 2020 6:09 AM

Update
Stoploss Trailed
Price @ Update
₹2,132.05
Original SL
₹2,128
New SL
2130.0
Athul @athul-S1OeuliUP
Oct 12, 2020 6:10 AM

Update
Stoploss Trailed
Price @ Update
₹2,132.2
Original SL
₹2,130
New SL
2131.4
TrackerBot @trackerbot
Oct 12, 2020 6:11 AM

Update
Stoploss Hit
Exit Price
2131.4

Dr Lal Pathlabs has clarified that the data breach of patients was a result of misconfiguration in one of the company's minor web applications where temporary records were stored for operational purposes. It involved less than 0.5% of the records and the issue has been resolved s...
Read more...
Like
Reply
N
Reputation: 10,122 • Oct 9, 2020 2:23 AM
Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report
The data included patients’ booking details such as their name, address, phone number, email id, payment details, digital signature, and also the type of medical tests they had taken.
Moneycontrol
Like
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,157.9  ₹2,157.1
Price@Trade
₹2,158.95
Target Price
₹5,000
Stop Price
₹400
Valid Till
Oct 8, 2021 3:20 AM
Margin
₹899,510.7 approx for 417 Qty
Status
Exited
Exit Price
₹2,197.4
Net P&L
+₹16,805.1 (+1.87%)
Like
Reply (3)
See all replies
Kapil Sahu @kapilsahu
Oct 8, 2020 8:33 AM

Update
Entry Price Modified
Price @ Update
₹2,157.1
Original Entry Price
₹2,157.9
New Entry Price
₹2,157.1
TrackerBot @trackerbot
Oct 8, 2020 8:34 AM

Update
Trade Entered
Entry Price
₹2,157.1
Kapil Sahu @kapilsahu
Oct 20, 2020 4:34 AM

Update
Exited
Exit Price
₹2,197.4
Net P&L
+₹16,805.1 (+1.87%)
R
Reputation: -7,919 • Oct 8, 2020 3:26 AM

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,162
Price@Trade
₹2,164
Target Price
₹2,220
Stop Price
₹2,140
Valid Till
Oct 8, 2020 3:20 AM
Margin
₹216,200 approx for 100 Qty
Status
Exited
Exit Price
₹2,166.6
Net P&L
+₹460 (+0.21%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Oct 8, 2020 3:27 AM

Update
Trade Entered
Entry Price
₹2,162
RUBEN NAG @rubennag
Oct 8, 2020 3:28 AM

Update
Exited
Exit Price
₹2,166.6
Net P&L
+₹460 (+0.21%)
N
Reputation: 10,122 • Oct 8, 2020 2:18 AM
Trade Spotlight: Metropolis Healthcare, Dr Lal Pathlabs & Ambuja Cement in focus
Dr Lal Pathlabs gained more than 11 percent, Metropolis Healthcare was up more than 4 percent and Ambuja Cement which hit a 52-week high closed with gains of more than 4 percent.
Moneycontrol
Like
Reply

LALPATHLAB 2300 16%up 🔥: Crossed all targets latest 2250, next 2500 Sl 2040

Today 2129-2300 🔥

Like
Reply

Buzzing Stock: Dr Lal Pathlabs Top gainer on the Nifty Midcap index Gains as much as 9.1% to Rs 2,178 Biggest single-day gain in over two years Trading at an all-time high Up for the third straight day Has gained over 15% in the last three trading sessions Saw breakout above 50-D...
Read more...
1
Reply

Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 l...
Read more...
2
Reply

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,100  ₹2,130
Price@Trade
₹2,131.95
Target Price
₹2,300
Stop Price
₹1,900
Valid Till
Nov 6, 2020 3:20 AM
Margin
₹213,000 approx for 100 Qty
Status
Target Achieved
Exit Price
₹2,300
Net P&L
+₹17,000 (+7.98%)
Like
Reply (5)
See all replies

Update
Entry Price Modified
Price @ Update
₹2,143.9
Original Entry Price
₹2,125
New Entry Price
2130.0
TrackerBot @trackerbot
Oct 7, 2020 4:33 AM

Update
Trade Entered
Entry Price
2130.0
TrackerBot @trackerbot
Oct 7, 2020 8:23 AM

Update
Target Achieved
Exit Price
₹2,300

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,130  ₹2,126.05
Price@Trade
₹2,126
Target Price
₹2,250
Stop Price
₹2,060
Valid Till
Nov 6, 2020 3:20 AM
Margin
₹212,605 approx for 100 Qty
Status
Target Achieved
Exit Price
₹2,250
Net P&L
+₹12,395 (+5.83%)
Like
Reply (3)
See all replies
Dilip @dilip-B1ZR4snnI
Oct 7, 2020 3:44 AM

Update
Entry Price Modified
Price @ Update
₹2,126.05
Original Entry Price
₹2,130
New Entry Price
₹2,126.05
TrackerBot @trackerbot
Oct 7, 2020 3:45 AM

Update
Trade Entered
Entry Price
₹2,126.05
TrackerBot @trackerbot
Oct 7, 2020 8:21 AM

Update
Target Achieved
Exit Price
₹2,250
N
Reputation: 10,122 • Sep 30, 2020 4:56 AM
Buy Dr. Lal Pathlabs, target price Rs 2142: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 15710.09 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply
P
Reputation: 10,193 • Sep 23, 2020 6:12 AM

LALPATHLAB - 1354824

Dr. Lal Pathlabs Ltd. is trading right at the weekly support zone.
Likely to see bounce in the short term until 1800 level is protected on the downside on closing basis.
Technical parameters looks positive as of now.
Keep a watch.
Like
Reply

LALPATHLAB - chart - 1327409
View - Dr Lalpathlabs Ltd LTP 1974.80/-Rs Action - Buy
Target Price 2300/-Rs
Stop L...
Read more...
2
Reply (1)
See all replies
Alpha Signals @ravikanthchopperla
Oct 7, 2020 4:26 AM

Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 l...

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹1,960
Price@Trade
₹1,961.85
Target Price
₹2,020
Stop Price
₹1,900
Valid Till
Oct 16, 2020 3:20 AM
Margin
₹196,000 approx for 100 Qty
Status
Exited
Exit Price
₹1,965.1
Net P&L
+₹510 (+0.26%)
Like
Reply (2)
See all replies
TrackerBot @trackerbot
Sep 16, 2020 3:24 AM

Update
Trade Entered
Entry Price
₹1,960
Dilip @dilip-B1ZR4snnI
Sep 16, 2020 4:02 AM

Update
Exited
Exit Price
₹1,965.1
Net P&L
+₹510 (+0.26%)
N
Reputation: 10,122 • Sep 14, 2020 5:08 AM
Select mid & smallcap stocks can provide the necessary alpha: Sacchitanand Uttekar
We expect markets to remain choppy throughout the week. Most of the price based evidence is pointing towards a broad range action within 11250-11750 with 11550 as its breakeven zone.
Moneycontrol
Like
Reply
N
Reputation: 10,122 • Sep 5, 2020 10:11 AM
Reopening of economy, increased testing, no mask use led to rise in COVID-19 cases in Delhi: Experts
The national capital has reported coronavirus cases in excess of 2,000 for four consecutive days since September 1. On Friday, the daily cases count stood at 2,914.
The Economic Times
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • LALPATHLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization8,783.99
    Enterprise Value8,305.89
    Price to Earnings43.63
    Price to Book Value9.44
    Return on Capital Employed0.33
    Return on Equity0.21
    Face Value10
    Dividend Yield0.01
  • LALPATHLAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    3-Aug-20Prabhudas LilladherSell1,006
    19-May-20Prabhudas LilladherSell895
    4-Feb-20Prabhudas LilladherHold1,797
    23-Aug-19Karvy Stock BrokingHold1,285
    14-Aug-19Prabhudas LilladherAccumulate1,120
    LALPATHLAB Brokerage Price Target
  • LALPATHLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 1822852332.4522252234.9
    Jan 152331.852353.22281.652295.45
    Jan 142400240523262331.85
    Jan 1323932405.42375.12396.25
    Jan 122387.62413.8523752389.85
  • LALPATHLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,323.87
    30 Day Moving Average₹2,277.5
    50 Day Moving Average₹2,256.28
    100 Day Moving Average₹2,126.29
    200 Day Moving Average₹1,889.32
  • LALPATHLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,024881.870.16
    Operating Profit256229.090.12
    Profit Before Tax255222.90.14
    Net Income167147.210.13
  • LALPATHLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds9317790.2
    Total Liabilities1361210.12
    Total Assets1,0669000.18
  • LALPATHLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity1891670.13
    Cash from Investing Activity-165-137.650.2
    Cash from Financing Activity12-33.78-1.36
    Net Cash Flow36-4.43-9.13
  • LALPATHLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.190.2
    Return on Equity0.210.24
    Return on Capital Employed0.330.36
  • LALPATHLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.61
    3 Year CAGR Growth in Operating Profit0.7
    3 Year CAGR Growth in EBIDTA0.74
    3 Year CAGR Growth in Net Income0.9
    3 Yr CAGR Growth - Diluted EPS0.25
  • LALPATHLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.43
    5 Year CAGR Growth in Operating Profit1.96
    5 Year CAGR Growth in EBIDTA2.19
    5 Year CAGR Growth in Net Income2.42
    3 Yr CAGR Growth - Diluted EPS-0.79
  • LALPATHLAB - Recent News

    keyboard_arrow_down
    NewsBot
    Today 4:58 AM
    Dr. Lal PathLabs Q3 PAT Seen Up 27.4% YoY To Rs. 54.1 Cr: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Nov 23, 2020 4:01 AM
    Add Dr. Lal Pathlabs, target price Rs 2430: ICICI Securities
    The Economic Times
    NewsBot
    Nov 6, 2020 10:36 AM
    Dr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 cr
    The Economic Times
    NewsBot
    Nov 6, 2020 9:03 AM
    Dr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoY
    Moneycontrol
    NewsBot
    Oct 9, 2020 2:23 AM
    Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report
    Moneycontrol
    NewsBot
    Sep 30, 2020 4:56 AM
    Buy Dr. Lal Pathlabs, target price Rs 2142: ICICI Securities
    The Economic Times
    NewsBot
    Sep 5, 2020 10:11 AM
    Reopening of economy, increased testing, no mask use led to rise in COVID-19 cases in Delhi: Experts
    The Economic Times
    NewsBot
    Aug 9, 2020 2:38 AM
    Hold Dr. Lal PathLabs; target of Rs 1995: Geojit
    Moneycontrol
    NewsBot
    Aug 8, 2020 6:13 AM
    Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Jul 31, 2020 9:56 AM
    Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 crore
    The Economic Times
  • LALPATHLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020